Jan founded Arboretum Ventures on the premise that innovation is key to delivering value in healthcare, a principle she developed working in the medical device industry for over two decades. Her investments focus on promising medical technologies that enable meaningful healthcare system savings while maintain great clinical outcomes. Jan has led and held board seats in more than a dozen investments across four funds including notable exits with HandyLab, Esperion (Nasdaq: ESPR), CardioMEMS, and NxThera.
Prior to co-founding Arboretum, Jan spent 20 years in entrepreneurial healthcare companies. She was previously President & Founder of Strategic Marketing Consultants advising healthcare start-ups and major medical device companies. Jan also held key management roles in marketing, clinical research, and sales for two successful medical device start-ups, Advanced Cardiovascular Systems and Devices for Vascular Intervention. Each of these companies was acquired by Eli Lilly and became the foundation for Guidant Corporation. Earlier in her career, Jan was an engineer and product manager for Procter & Gamble.
Since 2015, Jan has been a member of the Board of Directors of the National Venture Capital Association (NVCA) and will assume the role of Board Chair in 2019. Jan has been recognized as the 2015 Crain’s Newsmaker of the Year and as one of Crain’s Most Influential Women in 2016. She earned a BS in Bioengineering from the University of California at Berkeley and an MBA from the Wharton School at the University of Pennsylvania.
PREVIOUS PORTFOLIO INVOLVEMENT
Esperion Therapeutics (Nasdaq: ESPR)
nVision Medical (acquired)
Uptake Medical (acquired)
ACTIVITIES AND AFFILIATIONS
Board of Directors and Executive Committee, National Venture Capital Association
Former Chair, Michigan Venture Capital Association
Member, Saint Joseph Mercy Health System Board of Directors
ASSISTANT: Amanda Goldstein